Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021

This case-control study examines estimated COVID-19 messenger RNA vaccination effectiveness against SARS-CoV-2 infection from January to September 2021 among fully vaccinated male veterans aged 65 years or older.

Detalles Bibliográficos
Autores principales: Young-Xu, Yinong, Zwain, Gabrielle M., Powell, Ethan I., Smith, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674742/
https://www.ncbi.nlm.nih.gov/pubmed/34910155
http://dx.doi.org/10.1001/jamanetworkopen.2021.38975
Descripción
Sumario:This case-control study examines estimated COVID-19 messenger RNA vaccination effectiveness against SARS-CoV-2 infection from January to September 2021 among fully vaccinated male veterans aged 65 years or older.

Ejemplares similares